AI-assisted analysis based on the official CRS summary. Source version: Jul 24, 2026. Analysis updated: Sep 15, 2026.
01 — The Text
What.
- Prohibits Medicare, Medicaid, and private health insurers from covering organ transplants performed in China
- Prohibits coverage of transplants involving organs not procured through the U.S. Organ Procurement and Transplantation Network
- Prohibits U.S. health care providers from performing such transplants or providing related services
- Allows exceptions for life-saving services necessary as a result of a transplant
- Establishes criminal and civil penalties for violations
02 — The Stakes
So what?
- Official summary does not specify the magnitude of penalties or enforcement mechanisms
- Official summary does not establish documented effects on transplant access, patient outcomes, or insurance costs
- Official summary does not address how exceptions for life-saving services would be defined or administered
- No information provided on current volume of organ transplants from China or affected populations
03 — The Path
Now what?
- Bill was introduced in the House on March 14, 2025
- Referred to the Committee on Energy and Commerce and the Committee on Ways and Means on March 14, 2025
- No further action has been recorded
Legislative History
Actions.
- Mar 14, 2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 14, 2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 14, 2025 — Introduced in House
- Mar 14, 2025 — Introduced in House